Technology
Anthropic's Claude AI uncovers new enzyme system resembling CRISPR
Reported by Manish Reddy (Senior Writer) · Indian Express - Technology ·
Reported by one source so far
Representative image · PexelsAnthropic announced that its Claude artificial‑intelligence model has uncovered a previously unknown enzyme system that mirrors features of CRISPR gene‑editing tools. The discovery marks the first biological result from the startup’s new life‑science research program. Claude examined massive DNA data sets and spotted an unusual arrangement built around a reverse transcriptase enzyme, which copies RNA back into DNA. The company has called the arrangement array‑associated reverse transcriptases, or ART. ART includes repeating DNA segments that look like the pattern blocks used by CRISPR. While earlier studies had noted the reverse transcriptase itself, Claude was the first to identify the broader system, including a series of non‑coding DNA pieces and an extra protein whose role is still unknown. The breakthrough follows reports that Anthropic has opened a wet‑lab facility in the San Francisco Bay region as it expands beyond purely computer‑based work into drug and life‑science research.
ExplainerWhy this matters
What Happened
Anthropic’s Claude AI scanned large genetic databases and identified a novel set of DNA elements centered on a reverse transcriptase enzyme. The system, named array‑associated reverse transcriptases (ART), shows repeating DNA motifs similar to those used in CRISPR gene‑editing.
Why It Matters
Finding a natural system that mimics CRISPR could give scientists new tools for precise genetic modifications. Because the reverse transcriptase can copy RNA into DNA, the ART system might offer alternative pathways for editing genes or creating synthetic biology applications. Moreover, the AI‑driven discovery demonstrates how machine learning can accelerate the hunt for biologically useful molecules, potentially speeding up drug development and reducing research costs.
What Happens Next
Researchers will need to validate ART in the lab, determine the function of the unknown protein, and test whether the system can be harnessed for controlled gene editing. Anthropic’s new wet‑lab facility in the San Francisco Bay area will likely conduct these experiments. Success could lead to collaborations with biotech firms or academic labs, while any limitations will guide future AI‑assisted searches for similar biological systems.
More from today
Representative image · PexelsAutomobileVerified — Confirmed by a second source: Autocar IndiaImportant
JSW Motor's New Test SUV Spotted Next To Popular Mahindra Rival
Reported by Tanvi Pillai (Section Editor) · Rushlane ·
